Max Healthcare Institute Limited

Symbol: MAXHEALTH.NS

NSE

734.85

INR

Market price today

  • 73.1982

    P/E Ratio

  • 0.1485

    PEG Ratio

  • 714.17B

    MRK Cap

  • 0.00%

    DIV Yield

Max Healthcare Institute Limited (MAXHEALTH-NS) Financial Statements

On the chart you can see the default numbers in dynamics for Max Healthcare Institute Limited (MAXHEALTH.NS). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Max Healthcare Institute Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013

balance-sheet.row.cash-and-short-term-investments

014986.14864.26267.9
2807.9
116.4
899.7
202.5
99
1705.5
162.5

balance-sheet.row.short-term-investments

014558.61772.82
60
40.4
808.4
50
21.3
1484.4
0

balance-sheet.row.net-receivables

035194309.34259.7
5663.9
3895
0
0
0
0
0

balance-sheet.row.inventory

0762.3613.6538
433.7
260.1
282.7
231.2
232.2
185.4
151.9

balance-sheet.row.other-current-assets

0163.3215.8179.1
4441.6
4096.5
0
3054.9
2573.6
2014.4
0

balance-sheet.row.total-current-assets

019430.710002.911244.7
7683.2
4473
4321.9
3488.6
2904.8
3905.3
2327.5

balance-sheet.row.property-plant-equipment-net

022256.320583.217749.1
11482.9
10241.6
9959.1
10066.5
9791.2
7098.1
7447.7

balance-sheet.row.goodwill

024546.624546.624546.6
2853.9
2853.9
2853.9
2918.9
2918.9
210.2
210.2

balance-sheet.row.intangible-assets

026108.426557.323337.4
9517
9698.4
9841.8
9983.4
10134.5
246.6
238

balance-sheet.row.goodwill-and-intangible-assets

05065551103.947884
12370.9
12552.3
12695.7
12902.3
13053.4
456.8
448.2

balance-sheet.row.long-term-investments

05.120.210.4
24.6
5.1
0
1741.3
1741.9
-1210.1
0

balance-sheet.row.tax-assets

05430.410181.29.8
204.7
110.8
172.1
0
0
0
0

balance-sheet.row.other-non-current-assets

03241-0.18546.4
6477.5
6273.4
6065.5
3274.7
2959.7
4645
-7895.9

balance-sheet.row.total-non-current-assets

081587.881888.474199.7
30560.6
29183.2
28892.4
27984.8
27546.2
10989.8
7895.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
2574.2

balance-sheet.row.total-assets

0101018.591891.385444.4
38243.8
33656.2
33214.3
31473.4
30451
14895.1
12797.6

balance-sheet.row.account-payables

05434.64520.84356.9
2935.2
2915.9
2649.6
2137.2
2170.6
1551.9
1385.1

balance-sheet.row.short-term-debt

08451138877.4
5228.1
1126.9
1319.5
1022.2
1538.8
895.5
0

balance-sheet.row.tax-payables

026.800.5
0
0.4
0
0
0
0
0

balance-sheet.row.long-term-debt-total

06044.610188.712375.2
9921
8887
8469.8
7718.7
6488
3287.7
3363.5

Deferred Revenue Non Current

0117.3108.2114.1
16.3
10.3
38.8
6.4
1.8
53
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0846.8725.5654
288.8
264.7
796.3
246.8
220.7
145.7
1666.2

balance-sheet.row.total-non-current-liabilities

016466.921493.921288.3
13625.5
12624
18108.9
16587
14947.5
3441
3363.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
892.8

balance-sheet.row.capital-lease-obligations

01241.44060.24063
2151.8
25.3
35.2
44.3
278.1
94.2
0

balance-sheet.row.total-liab

026922.629066.629057.6
28369.7
24024.3
22874.3
20413.9
19168.8
6265.6
7307.6

balance-sheet.row.preferred-stock

073630.6056121.7
0
11633.4
0
0
0
0
0

balance-sheet.row.common-stock

09709.29696.19659.5
5372.4
5372.4
5372.4
5372.4
5334.1
4888.1
4272.8

balance-sheet.row.retained-earnings

012340.61476.1-4585.9
-4240.1
-4440.8
-4406.9
-4347.4
-4430.5
-4248.5
-4137

balance-sheet.row.accumulated-other-comprehensive-income-loss

0465.3275.5265.1
0
-2001.5
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-22049.851377-5073.6
8741.8
-931.6
9374.5
10034.5
10378.6
7989.9
-135.8

balance-sheet.row.total-stockholders-equity

074095.962824.756386.8
9874.1
9631.9
10340
11059.5
11282.2
8629.5
135.8

balance-sheet.row.total-liabilities-and-stockholders-equity

0101018.591891.385444.4
38243.8
33656.2
33214.3
31473.4
30451
14895.1
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0

balance-sheet.row.total-equity

074095.962824.756386.8
9874.1
9631.9
10340
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-

Total Investments

02065.420.210.4
12.3
10.4
808.4
1791.3
1763.2
274.3
0

balance-sheet.row.total-debt

06889.611326.713252.6
15149.1
10013.9
9789.3
8740.9
8026.8
4183.2
0

balance-sheet.row.net-debt

06462.18235.36986.7
12401.2
9937.9
9698
8588.4
7949.1
3962.1
-162.5

Cash Flow Statement

The financial landscape of Max Healthcare Institute Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013

cash-flows.row.net-income

010637.27389-686.5
890.8
83.2
-152
47
-189.6
-381.4
-646.5

cash-flows.row.depreciation-and-amortization

02321.92211.21740.9
1197.4
1026.4
973.9
1076.1
912.1
494.4
514.5

cash-flows.row.deferred-income-tax

0-1789-1469.1549.9
0
0
0
-252
3339.3
-229.8
-191.8

cash-flows.row.stock-based-compensation

0343.5339.3265.1
0
0
0
3.6
30.8
1.6
4.6

cash-flows.row.change-in-working-capital

0806.4-1319.6-3762.5
-469.4
-481.3
-254.9
88.7
2720.3
228.2
187.2

cash-flows.row.account-receivables

0647.429.1560.6
-314.3
-778
0
0
0
249.2
176.9

cash-flows.row.inventory

0-148.7-75.6172.5
-173.1
22.6
-51.5
1
-46.8
-21
10.3

cash-flows.row.account-payables

0987.4-447.8-4779
-118.9
281.2
0
0
0
0
0

cash-flows.row.other-working-capital

0-679.7-825.3283.4
136.9
-7.1
-203.4
87.7
2767.1
0
0

cash-flows.row.other-non-cash-items

0-228.2334.13071.7
879.4
261.2
255.3
597.3
412.1
44
672.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-3356.1-5613.1-1184.2
-887.4
-1157.3
-655.4
-1150.2
-16055.7
-542.6
-514.6

cash-flows.row.acquisitions-net

0-4.8-1071.616.2
-21359.8
-757.6
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-10757.7-1711.90
-21.5
-5.1
-733.2
-55.4
0
0
0

cash-flows.row.sales-maturities-of-investments

0997.12783.50
21359.8
762.7
0
0
1493.6
0
0

cash-flows.row.other-investing-activites

01251.4-2104.6438
-357.9
992
385
167.6
1161
-1458.3
207

cash-flows.row.net-cash-used-for-investing-activites

0-11870.1-7717.7-730
-1266.8
-165.3
-1003.6
-1038
-13401.1
-2000.9
-307.6

cash-flows.row.debt-repayment

0-1398.8-2496-8326.3
-1298.3
-306.8
0
-336.1
0
0
0

cash-flows.row.common-stock-issued

013.136.611791.6
18575.2
0
0
0
2834.7
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-1499.9-482.3-1552
-15836.4
-432.7
0
-145.8
3198.6
1761.8
-517

cash-flows.row.net-cash-used-provided-by-financing-activities

0-2885.6-2941.71913.3
1440.5
-739.5
120.1
-481.9
6033.3
1761.8
-517

cash-flows.row.effect-of-forex-changes-on-cash

0002793.9
-1637.8
0
0
0
0
-52.4
191.6

cash-flows.row.net-change-in-cash

0-2663.9-3174.55155.8
2671.9
-15.3
-61.2
40.8
-142.8
95.3
99.3

cash-flows.row.cash-at-end-of-period

0427.53091.46265.9
2747.9
76
91.3
152.5
111.7
194.6
99.3

cash-flows.row.cash-at-beginning-of-period

03091.46265.91110.1
76
91.3
152.5
111.7
254.5
99.3
0

cash-flows.row.operating-cash-flow

012091.87484.91178.6
2498.2
889.5
822.3
1560.7
7225
386.8
732.3

cash-flows.row.capital-expenditure

0-3356.1-5613.1-1184.2
-887.4
-1157.3
-655.4
-1150.2
-16055.7
-542.6
-514.6

cash-flows.row.free-cash-flow

08735.71871.8-5.6
1610.8
-267.8
166.9
410.5
-8830.7
-155.8
217.7

Income Statement Row

Max Healthcare Institute Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of MAXHEALTH.NS is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013

income-statement-row.row.total-revenue

04562638831.924824.1
18617.1
16714.4
17116.3
14379.5
12568.2
7895.7
9444.6

income-statement-row.row.cost-of-revenue

09220.192295944.1
3917.8
3654.6
4493.9
4231
3987.1
4363.7
5387.9

income-statement-row.row.gross-profit

036405.929602.918880
14699.3
13059.8
12622.4
10148.5
8581.1
3532
4056.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0268.6109.6100
84.5
65.4
7589.9
108.7
111.8
0
0

income-statement-row.row.operating-expenses

026322.521848.416040.8
12910.9
12499
12377.3
9569.3
8434.6
-3790.7
-4273.9

income-statement-row.row.cost-and-expenses

035542.631077.421984.9
16828.7
16153.6
16871.2
13800.3
12421.7
573
1114

income-statement-row.row.interest-income

01123.8750.9767.3
157.1
116.1
132.7
10.4
6
0
0

income-statement-row.row.interest-expense

0838.6900.11710
1471.2
961.8
913.6
953.8
645
-122.7
-425.7

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0397-190.6-3347.5
106.4
-485.9
-915.7
-960
-620.1
-105.1
-411.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0268.6109.6100
84.5
65.4
7589.9
108.7
111.8
0
0

income-statement-row.row.total-operating-expenses

0397-190.6-3347.5
106.4
-485.9
-915.7
-960
-620.1
-105.1
-411.6

income-statement-row.row.interest-expense

0838.6900.11710
1471.2
961.8
913.6
953.8
645
-122.7
-425.7

income-statement-row.row.depreciation-and-amortization

02321.92211.21740.9
1197.4
1026.4
973.9
1076.1
912.1
494.4
514.5

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

010240.27579.62430.5
482.2
569.1
650.8
1007
430.5
-276.3
-231.3

income-statement-row.row.income-before-tax

010637.27389-686.5
890.8
83.2
-264.9
47
-189.6
-381.4
-642.9

income-statement-row.row.income-tax-expense

0-397.91338.5458.5
-62.6
85.1
22.4
-43.5
36.5
0
3.6

income-statement-row.row.net-income

011035.16050.5-1375.5
953.4
-30.1
-287.3
90.5
-226.1
-381.4
-646.5

Frequently Asked Question

What is Max Healthcare Institute Limited (MAXHEALTH.NS) total assets?

Max Healthcare Institute Limited (MAXHEALTH.NS) total assets is 101018500000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.833.

What is company free cash flow?

The free cash flow is 3.948.

What is enterprise net profit margin?

The net profit margin is 0.203.

What is firm total revenue?

The total revenue is 0.259.

What is Max Healthcare Institute Limited (MAXHEALTH.NS) net profit (net income)?

The net profit (net income) is 11035100000.000.

What is firm total debt?

The total debt is 6889600000.000.

What is operating expences number?

The operating expences are 26322500000.000.

What is company cash figure?

Enretprise cash is 0.000.